Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$11,758,633
+$1,895,897 QoQ
Shares Held
46,728
+3.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.88%
of 13F equity value
Holder Rank
#844
of 4,153 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sargent Investment Group, LLC holds $34,963,451 across 9 Drug Manufacturers - General names. ABBV ranks #1 (33.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
46,728 | $11,758,633 | |
| 2 | JNJ |
Johnson & Johnson
|
33,156 | $8,420,629 | |
| 3 | LLY |
ELI LILLY & Co
|
5,913 | $7,092,230 | |
| 4 | MRK |
Merck & Co., Inc.
|
25,863 | $3,323,395 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
36,270 | $2,089,877 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
10,842 | $1,369,778 | |
| 7 | AMGN |
Amgen Inc
|
1,276 | $462,065 | |
| 8 | PFE |
Pfizer Inc
|
9,550 | $229,964 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,758,633 | 46,728 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $9,862,736 | 45,348 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $10,072,981 | 44,085 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $10,097,227 | 43,609 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,730,887 | 41,649 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,091,871 | 38,621 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $6,448,022 | 36,286 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $9,313,551 | 47,162 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $7,837,091 | 45,692 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $800,511 | 4,396 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,327,937 | 8,569 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,184,132 | 7,944 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,138,737 | 8,452 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $1,420,305 | 8,912 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $1,361,241 | 8,423 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $1,133,806 | 8,448 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $1,192,810 | 7,788 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $1,199,289 | 7,398 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,008,459 | 7,448 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $781,841 | 7,248 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $797,153 | 7,077 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $671,180 | 6,202 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $375,239 | 3,502 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $227,909 | 2,602 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $232,195 | 2,365 | Shares | Sole | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||